A phase II clinical trial is underway at the Department of Gastroenterology at Royal Perth Hospital in Australia among several medical institutes and the Cell and Tissue Therapies WA.
Out of 15 patients that completed the trial, 12 of them responded to the treatment. Eight of them went into disease remission.
More Articles on Gastroenterology:
Olympus Launches Medical Technology Website
Drs. Renjy Vattasseril, Anthony Masciarelli Join Cape Regional Physicians Associates
NIH Grants Medical College of Wisconsin $2M to Study GERD
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.